Association between hedonic hunger and glycemic control in non-obese and obese patients with type 2 diabetes

被引:11
|
作者
Cheung, Lorena Tsui Fun [1 ]
Ko, Gary Tin Choi [1 ]
Chow, Francis Chun Chung [1 ]
Kong, Alice Pik Shan [1 ]
机构
[1] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China
关键词
Hedonic hunger; Obesity; Type; 2; diabetes; WEIGHT; POWER; RISK;
D O I
10.1111/jdi.12800
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims/IntroductionHigher hedonic hunger has been observed in obese individuals compared with those without obesity, but little is known about its association with glycemic management. We aimed to examine the association between hedonic hunger and glycemic control in non-obese and obese patients with type 2 diabetes. Materials and MethodsBetween April and November 2016, a total of 211 type 2 diabetes patients who underwent comprehensive diabetes assessments at a university-affiliated hospital were recruited into two groups according to body mass index: non-obese (body mass index 18.5-24.9kg/m(2)) and obese (body mass index 30kg/m(2)) groups. All participants completed the Chinese version of the Power of Food Scale (PFS) for assessment of hedonic hunger. Good glycemic control was defined as glycated hemoglobin <7.0%. ResultsCompared with the non-obese group, the obese group showed higher PFS aggregated and subscale food available' scores (both P<0.05). After adjustment for age, sex, disease duration of diabetes and insulin use, there were positive associations of glycated hemoglobin with PFS aggregated, subscale food available' and food present' scores in the obese group (all P for trend <0.05). The PFS aggregated score was negatively associated with good glycemic control in obese type 2 diabetes patients after adjustment using logistic regression analysis (adjusted odds ratio 0.42, 95% confidence interval 0.20-0.91, P=0.027). By contrast, such associations were not observed in non-obese type 2 diabetes patients. ConclusionsHedonic hunger had an independent and inverse association with good glycemic control in obese Chinese patients with type 2 diabetes, but not in their counterparts without obesity.
引用
收藏
页码:1135 / 1143
页数:9
相关论文
共 50 条
  • [1] Association between Serum Vitamin D Level and Glycemic and Inflammatory Markers in Non-obese Patients with Type 2 Diabetes
    Haidari, Fatemeh
    Zakerkish, Mehrnoosh
    Karandish, Majid
    Saki, Azadeh
    Pooraziz, Sakineh
    [J]. IRANIAN JOURNAL OF MEDICAL SCIENCES, 2016, 41 (05) : 367 - 373
  • [2] Rosiglitazone is effective in obese and non-obese patients with Type 2 diabetes
    Deacon, L
    Donnelly, S
    Stewart, M
    Hand, L
    [J]. DIABETES, 2001, 50 : A433 - A433
  • [3] Differential Responses to Acarbose Between Obese and Non-obese Patients with Type 2 Diabetes Mellitus
    Chou, Chien-Wen
    Ou, Horng-Yih
    Hsiao, Shu-Hwa
    Wu, Ta-Jen
    [J]. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2006, 4 (02) : 63 - 69
  • [4] Better Long-Term Glycemic Control in Non-Obese Type Than Obese Type in Young Korean Type 2 Diabetes
    Jang, Yun-Mi
    Kim, Dong-Lim
    Lee, Eun Jung
    Song, Kee-Ho
    Kim, Suk Kyeong
    [J]. DIABETES, 2011, 60 : A695 - A695
  • [5] Comparison of Plasma Exosome Proteomes Between Obese and Non-Obese Patients with Type 2 Diabetes Mellitus
    Wang, Yanjun
    Wu, You
    Yang, Shuangzhu
    Chen, Yan
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY, 2023, 16 : 629 - 642
  • [6] Population pharmacokinetics of metformin in obese and non-obese patients with type 2 diabetes mellitus
    Christophe Bardin
    Estelle Nobecourt
    Etienne Larger
    François Chast
    Jean-Marc Treluyer
    Saik Urien
    [J]. European Journal of Clinical Pharmacology, 2012, 68 : 961 - 968
  • [7] Rosiglitazone is effective in both obese and non-obese patients with type 2 diabetes.
    Cranmer, H
    Jones, NP
    Patwardhan, R
    [J]. DIABETOLOGIA, 1999, 42 : A228 - A228
  • [8] Population pharmacokinetics of metformin in obese and non-obese patients with type 2 diabetes mellitus
    Bardin, Christophe
    Nobecourt, Estelle
    Larger, Etienne
    Chast, Francois
    Treluyer, Jean-Marc
    Urien, Saik
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 68 (06) : 961 - 968
  • [9] Cholesterol metabolism in obese and non-obese subjects with type 2 diabetes
    Simonen, PP
    Gylling, HK
    Miettinen, TA
    [J]. CIRCULATION, 2000, 102 (18) : 283 - 283
  • [10] In Japanese Patients With Type 2 Diabetes, Clinical Predictors for Effectiveness of Liraglutide Treatment are Different between Obese and Non-Obese Patients
    Sasaki, Shuji
    Sako, Yasuhiro
    Hirata, Eiichi
    Sakai, Yoshiyuki
    Inoguchi, Toyoshi
    Takayanagi, Ryoichi
    [J]. DIABETES, 2012, 61 : A612 - A612